
Michele Redell
Associate Director · Baylor College of Medicine
Credentials: · · ·
History
- Present
- 2001–2002
- 1998–2001
Pediatrics
Research
Blood · 2011 · First of 5 authors · Corresponding · 228 citations
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
Journal of Hematology & Oncology · 2016 · 91 citations
Targeting transcription factors for cancer therapy
Review · Current Pharmaceutical Design · 2005 · First of 2 authors · 80 citations

16 papers · 2 as a fellow

8 papers

4 papers

4 papers

4 papers

3 papers

3 papers

3 papers
Grants
- 2019–2022
National Cancer Institute · R21
Contact PI · $421.7K · Baylor College of Medicine
- 2014–2019
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
National Cancer Institute · R01
Contact PI · $2M · Baylor College of Medicine
- 2008–2013
Stat3 Isoforms in Maturation and Survival of Normal and Malignant Myeloid Cells
National Heart, Lung, and Blood Institute · K08
Contact PI · $640.9K · Baylor College of Medicine
Clinical trials
- 2022–2030
Principal investigator · Recruiting · Phase 1, Phase 2
PedAL BCU, LLC
- 2012
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
Principal investigator · Completed
Children's Oncology Group
- 2011
Principal investigator · Completed
Children's Oncology Group
- 2010
Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia
Principal investigator · Completed
Children's Oncology Group


